SCHEDULE: Janus Henderson Amends Entrada Therapeutics Stake
Beneficial Ownership Report
Janus Henderson Group plc has filed an Amendment No. 2 to Schedule 13G, reporting a 4.0% beneficial ownership stake in Entrada Therapeutics, Inc. as of June 30, 2025.
Summary
- Janus Henderson Group plc reported beneficial ownership of 1,521,281 shares of Entrada Therapeutics, Inc. common stock.
- This represents 4.0% of Entrada Therapeutics' common stock.
- The filing is an Amendment No. 2 to a Schedule 13G, indicating an update to a previously reported passive stake.
- Janus Henderson Group plc, through its indirect subsidiaries JHIUS, JHIUKL, and JHIAIFML, holds shared voting and dispositive power over all reported shares.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 5
Explanation: The filing is a routine regulatory disclosure of beneficial ownership, providing factual information without indicating positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Industry Context
This filing is a routine disclosure of a passive investment stake by an asset manager in a therapeutics company. It does not provide broader industry trends or competitive analysis.
Stakeholder Impact
- The filing provides transparency to shareholders and the market regarding Janus Henderson Group plc's passive investment stake in Entrada Therapeutics, Inc.
Key Dates
| Date | Description |
|---|---|
| 2022-12-09 | Date of Power of Attorney execution by Janus Henderson Group plc. |
| 2025-06-30 | Date of event which requires filing of this statement, indicating the beneficial ownership percentage. |
| 2025-08-14 | Signature date of the Schedule 13G Amendment No. 2. |
Keywords
Entrada Therapeutics, Janus Henderson, SEC Filing, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.